Skip to main content
. 2024 Feb 29;19(2):e0298151. doi: 10.1371/journal.pone.0298151

Table 3. Associated metabolic factors with remission of NAFLD based on abdominal ultrasonography at month 12.

Model 1 Model 2
OR 95% CI P OR 95% CI P
BMI, kg/m2 0.49 0.33, 0.74 0.001 0.63 0.31, 1.26 0.193
WC, cm 0.81 0.72, 0.92 0.001 0.82 0.67, 1.00 0.050
AST, IU/L 0.98 0.95, 1.01 0.175 0.96 0.89, 1.05 0.373
ALT, IU/L 0.98 0.95, 1.00 0.041 1.02 0.96, 1.08 0.522
r-GTP, IU/L 0.99 0.98, 1.01 0.386 1.00 0.97, 1.04 0.885
Albumin, g/dL 5.10 0.48, 54.68 0.178 0.93 0.04, 24.25 0.967
TC, mg/dL 1.00 0.99, 1.01 0.909 1.00 0.98, 1.02 0.725
TG, mg/dL 1.00 0.99, 1.00 0.188 1.00 1.00, 1.01 0.351
HDL, mg/dL 1.12 1.04, 1.20 0.002 1.17 1.03, 1.32 0.014
HbA1c, % 0.88 0.40, 1.94 0.757 0.87 0.18, 4.09 0.858
Insulin, mIU/L 0.92 0.84, 1.01 0.079 0.98 0.87, 1.12 0.791

Note: model 1 was adjusted for age, sex, and baseline values of each variable

model 2 was adjusted for age, sex, and all variables at baseline and month 12

Abbreviation: NAFLD, non-alcoholic fatty liver disease; BMI, body mass index; WC, waist circumference; AST, aminotransferase; ALT, alanine aminotransferase; r-GTP, gamma-glutamyl transpeptidase; TC, total cholesterol; TG, triglyceride; HDL-C, HDL-cholesterol; HbA1C, hemoglobin A1C.